Cargando…

Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid

In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaqoob, Sana, Nasim, Nourina, Khanam, Rahila, Wang, Yan, Jabeen, Almas, Qureshi, Urooj, Ul-Haq, Zaheer, El-Seedi, Hesham R., Jiang, Zi-Hua, Khan, Farooq-Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956706/
https://www.ncbi.nlm.nih.gov/pubmed/33652837
http://dx.doi.org/10.3390/molecules26051272
_version_ 1783664498038538240
author Yaqoob, Sana
Nasim, Nourina
Khanam, Rahila
Wang, Yan
Jabeen, Almas
Qureshi, Urooj
Ul-Haq, Zaheer
El-Seedi, Hesham R.
Jiang, Zi-Hua
Khan, Farooq-Ahmad
author_facet Yaqoob, Sana
Nasim, Nourina
Khanam, Rahila
Wang, Yan
Jabeen, Almas
Qureshi, Urooj
Ul-Haq, Zaheer
El-Seedi, Hesham R.
Jiang, Zi-Hua
Khan, Farooq-Ahmad
author_sort Yaqoob, Sana
collection PubMed
description In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 exhibits an exceptional IC(50) value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research.
format Online
Article
Text
id pubmed-7956706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79567062021-03-16 Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid Yaqoob, Sana Nasim, Nourina Khanam, Rahila Wang, Yan Jabeen, Almas Qureshi, Urooj Ul-Haq, Zaheer El-Seedi, Hesham R. Jiang, Zi-Hua Khan, Farooq-Ahmad Molecules Communication In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5–6 and 8a–8b. The compound 5 exhibits an exceptional IC(50) value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research. MDPI 2021-02-26 /pmc/articles/PMC7956706/ /pubmed/33652837 http://dx.doi.org/10.3390/molecules26051272 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Yaqoob, Sana
Nasim, Nourina
Khanam, Rahila
Wang, Yan
Jabeen, Almas
Qureshi, Urooj
Ul-Haq, Zaheer
El-Seedi, Hesham R.
Jiang, Zi-Hua
Khan, Farooq-Ahmad
Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title_full Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title_fullStr Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title_full_unstemmed Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title_short Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid
title_sort synthesis of highly potent anti-inflammatory compounds (ros inhibitors) from isonicotinic acid
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956706/
https://www.ncbi.nlm.nih.gov/pubmed/33652837
http://dx.doi.org/10.3390/molecules26051272
work_keys_str_mv AT yaqoobsana synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT nasimnourina synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT khanamrahila synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT wangyan synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT jabeenalmas synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT qureshiurooj synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT ulhaqzaheer synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT elseediheshamr synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT jiangzihua synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid
AT khanfarooqahmad synthesisofhighlypotentantiinflammatorycompoundsrosinhibitorsfromisonicotinicacid